Frontlight ResearchEarly access
Trial site
University of Cincinnati - PARENT
- 2running trials
The trials here
What the 2 trials at this site are about, from their registry records.
- Conditions
- Lung cancer2 trials
- Bladder cancer1 trial
- Kidney cancer1 trial
- Ovarian cancer1 trial
- Phase
- Phase 21 trial
- Phase 31 trial
- Status
- Active, not recruiting2 trials
- Lead sponsor
- EMD Serono Research & Development Institute, Inc.2 trials
Running trials
Active, not recruiting
Active, not recruiting
Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)
Site data: ClinicalTrials.govUpdated 12 Nov 2026